We have interviewed Luisa Lopes, the Leader of the Neurobiology of Ageing & Disease group at the Institute of Molecular Medicine (iMM) in Lisbon. In this short interview, Luisa talks about her research. She shares her opinion about the FDA approved Aduhelm (aducanumab) and how COVID-19 neurological complications are being addressed.
We have interviewed Susana Gonçalves, Operations Director at TechnoPhage. Susana talks about her experience in working with VectorB2B in the management of TechnoPhage clinical trials and shares her opinion about how she thinks companies like TechnoPhage could benefit from working with VectorB2B. https://www.youtube.com/watch?v=YFcnz7r28Ng
We have interviewed Mariana Almeida, Innovation & Pharmaceutical Development Manager at Grupo Medinfar. During this short interview, Mariana talks about Medinfar and the role of VectorB2B as a one-stop-shop, offering full drug development services. https://www.youtube.com/watch?v=D-1kYWt9gi4&t=1s
We have interviewed Francisco Ambrósio, Director of the Coimbra Institute for Clinical and Biomedical Research (iCBR) at Faculty of Medicine Coimbra University. During this short interview, Francisco talks about the research performed in his laboratory and how VectorB2B can help to bridge the translational gap. https://www.youtube.com/watch?v=OZwY5la4j6A